(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 2.16% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 130.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.12%.
Perrigo Co's revenue in 2025 is $4,281,800,000.On average, 6 Wall Street analysts forecast PRGO's revenue for 2025 to be $614,628,824,194, with the lowest PRGO revenue forecast at $587,792,142,439, and the highest PRGO revenue forecast at $636,786,289,643. On average, 6 Wall Street analysts forecast PRGO's revenue for 2026 to be $617,656,552,392, with the lowest PRGO revenue forecast at $588,067,390,457, and the highest PRGO revenue forecast at $649,998,194,507.
In 2027, PRGO is forecast to generate $629,905,089,193 in revenue, with the lowest revenue forecast at $590,957,494,646 and the highest revenue forecast at $665,824,955,542.